377 related articles for article (PubMed ID: 9867153)
41. [Improved detection of fill-in using sublingual nitroglycerin in technetium-99m tetrofosmin exercise/rest single photon emission computed tomography one day protocol for old myocardial infarction].
Miyanaga H; Kunieda Y; Oguni A; Kamitani T; Kawasaki S; Takahashi T
J Cardiol; 1999 Mar; 33(3):135-43. PubMed ID: 10225193
[TBL] [Abstract][Full Text] [Related]
42. Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells.
Al-Saeedi FJ; Bitar M; Pariyani S
J Nucl Med Technol; 2011 Dec; 39(4):279-83. PubMed ID: 22080437
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy.
Kresnik E; Gallowitsch HJ; Mikosch P; Molnar M; Pipam W; Gomez I; Lind P
Eur J Nucl Med; 1997 Jul; 24(7):716-21. PubMed ID: 9211755
[TBL] [Abstract][Full Text] [Related]
44. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.
Arbab AS; Koizumi K; Toyama K; Araki T
J Nucl Med; 1996 Sep; 37(9):1551-6. PubMed ID: 8790217
[TBL] [Abstract][Full Text] [Related]
45. Gated technetium-99m-tetrofosmin SPECT and cine MRI to assess left ventricular contraction.
Gunning MG; Anagnostopoulos C; Davies G; Forbat SM; Ell PJ; Underwood SR
J Nucl Med; 1997 Mar; 38(3):438-42. PubMed ID: 9074534
[TBL] [Abstract][Full Text] [Related]
46. [Comparative study on the tumor accumulation of 99mTc-tetrofosmin and 99mTc-MIBI in rabbits bearing VX-2 cancer].
Otsuka N; Tamada T; Mimura H; Sone T; Morita K; Tomomitsu T; Yanagimoto S; Fukunaga M
Kaku Igaku; 1997 Oct; 34(10):939-43. PubMed ID: 9404102
[TBL] [Abstract][Full Text] [Related]
47. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.
Ishibashi M; Nishida H; Strauss HW; Kojima K; Fujito H; Watanabe J; Hiromatsu Y; Hayabuchi N
J Nucl Med; 1997 May; 38(5):706-11. PubMed ID: 9170432
[TBL] [Abstract][Full Text] [Related]
48. 99mTc isonitrils biophysical aspects in pulmonary tuberculosis. Part II. In vitro evaluation of 99mTc MIBI cellular uptake mechanism.
Stefănescu C; Rusu V; Azoicăi D; Hurjui I
Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):210-5. PubMed ID: 17595869
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of malignant and benign lung lesions with 99Tcm-tetrofosmin.
Atasever T; Gökcora N; Vural G; Cetin N; Oztürk C; Unlü M
Nucl Med Commun; 1996 Jul; 17(7):577-82. PubMed ID: 8843116
[TBL] [Abstract][Full Text] [Related]
50. 99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response.
Sükan A; Yapar Z; SAhin B; Kara O; Fuat Yapar A; CEtiner S; Kibar M
Nucl Med Commun; 2004 Aug; 25(8):777-85. PubMed ID: 15266171
[TBL] [Abstract][Full Text] [Related]
51. 99mTc-tetrofosmin scintigraphy in management of pulmonary tuberculosis.
Kumar R; Khullar S; Gupta R; Marwah A; Barai S; Malhotra A
J Nucl Med; 2000 Jun; 41(6):1120. PubMed ID: 10855645
[No Abstract] [Full Text] [Related]
52. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.
Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A
Lung; 2003; 181(2):103-11. PubMed ID: 12953149
[TBL] [Abstract][Full Text] [Related]
53. Washout rates of Tc-99m tetrofosmin in asymmetric septal hypertrophy.
Büyükdereli G; Kanadasi M; Kibar M
Ann Nucl Med; 2005 Feb; 19(1):29-33. PubMed ID: 15770970
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic utility of 99mTc-EDDA-tricine-HYNIC-Tyr3-octreotate SPECT for differentiation of active from inactive pulmonary tuberculosis.
Ahmadihosseini H; Abedi J; Ghodsi Rad MA; Zakavi SR; Knoll P; Mirzaei S; Sadeghi R
Nucl Med Commun; 2014 Dec; 35(12):1262-7. PubMed ID: 25222910
[TBL] [Abstract][Full Text] [Related]
55. Technetium-99m-tetrofosmin uptake in malignant lung tumours.
Başoğlu T; Sahin M; Coşkun C; Koparan A; Bernay I; Erkan L
Eur J Nucl Med; 1995 Jul; 22(7):687-9. PubMed ID: 7498232
[TBL] [Abstract][Full Text] [Related]
56. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
Giordano A; Meduri G; Marozzi P; Rubini G; Burroni L; Cappagli M
Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474
[TBL] [Abstract][Full Text] [Related]
57. Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.
Burggasser G; Hurtl I; Hauff W; Lukas J; Greifeneder M; Heydari B; Thaler A; Wedrich A; Virgolini I
J Nucl Med; 2003 Oct; 44(10):1547-55. PubMed ID: 14530465
[TBL] [Abstract][Full Text] [Related]
58. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation.
Spanu A; Schillaci O; Pirina P; Arru A; Madeddu G; Chessa F; Marongiu P; Solinas ME; Madeddu G
Oncol Rep; 2006 Oct; 16(4):763-9. PubMed ID: 16969491
[TBL] [Abstract][Full Text] [Related]
59. Uptake of 99mTc tetrofosmin in lymphoma cell lines: a comparative study with 99mTc sestamibi.
Ding HJ; Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A
Appl Radiat Isot; 2002 Jun; 56(6):853-6. PubMed ID: 12102342
[TBL] [Abstract][Full Text] [Related]
60. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
